Genome Medicine · 2018 · 101 citations · 7 references
MedicineMolecular BiologyOncologyEarly DetectionMolecular DiagnosticsMolecular OncologyCancer DetectionCancer Early DetectionCirculating Tumor CellsCirculating Tumor Dna AnalysisEarly Cancer DetectionLiquid BiopsyCirculating Cell-free Dna AnalysisCirculating Tumor Dna DetectionCirculating Tumor Dna TestingLiquid Biopsy DetectionLiquid Biopsy DiagnosticsTherapeutic Resistance MechanismsTherapy Resistance DetectionTherapy Resistance Monitoring
Progress in sensitive analytical approaches has opened new avenues for the detection of cells or products such as circulating cell-free DNA released by tumors. These 'liquid biopsies' are being explored in clinical trials for early cancer detection, prediction of recurrent disease, and assessment of therapeutic resistance mechanisms.
7
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen, Lu Li, Yuxuan Wang et al. · Science · 2018 · 2.8K citations
Medicine, Oncology, Cancer Screening +16
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh, Nicolai J. Birkbak, Gareth A. Wilson et al. · Nature · 2017 · 1.9K citations · Full text
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Giulia Siravegna, Benedetta Mussolin, Michela Buscarino et al. · Nature Medicine · 2015 · 1.1K citations · Full text
Medicine, Cancer Biology, Oncology +16